Business Wire

The Digital Cooperation Organization Launches “EconomiX” Magazine to Enhance Knowledge Sharing in the Digital Ecosystem

Share

The Digital Cooperation Organization (DCO), a global multilateral organization committed to enabling digital prosperity for all by accelerating the sustainable and inclusive growth of the digital economy, announced the launch of EconomiX magazine, a publication offering insights from international digital economy thought leaders into ways nations and organizations can seize the digital economy’s opportunities to spur digital transformation globally. By merging insights from different stakeholders from the public and private sectors, academia, and international organizations from DCO Member States and other countries, EconomiX provides a holistic view of the digital economy from different perspectives.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240527424476/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

1st Issue of the “EconomiX by the DCO” magazine (Graphic: AETOSWire)

The first edition of EconomiX covers a wide range of topics including global news on the digital economy, updates from DCO Member States, special articles on "Developing new AI business models" and "Digital upskilling -future-proof jobs". The theme of the magazine's first issue "Growth Unleashed - AI: Powering Economic Prosperity" delves into the world of artificial intelligence and its transformative impact on economies worldwide.

In addition to exclusive interviews with H.E. Dr. Bosun Tijani, Minister of Communications, Innovation and Digital Economy of the Federal Republic of Nigeria, and H.E. Paula Ingabire, Minister of Information and Communications Technology and Innovation of the Republic of Rwanda, and Ms. Deemah AlYahya, Secretary-General of the DCO, this issue features articles and interviews with a distinguished group of ministers, CEOs, and experts in technology and the digital economy.

Manel Bondi, DCO’s Chief of Digital Markets Growth, commented: "EconomiX stands as a catalyst for change and empowerment amidst the digital revolution. It fills an important gap with its focus on the economic dimension of technology as a key pillar to drive and sustain inclusive and meaningful economic growth across the globe. It demonstrates how communities, businesses, and governments can cooperate meaningfully and pave the way toward achieving digital prosperity for all. EconomiX is a platform that fosters knowledge sharing, innovation, and inspiration for our readers, and reflects our dedication to promoting cooperation to develop the global digital economy."

Addressing critical aspects of digital economic advancement like policy making, data transformation, digital updates, women empowerment, and thought leadership, EconomiX endeavors to guide its readers through the digital revolution. It aims to provide actionable insights, expert analysis, and case studies for navigating digital change, fostering an understanding of how to leverage digital transformation for economic and social prosperity.

The magazine is a vital tool for digital transformation, aimed at empowering change by fostering knowledge exchange, enhancing cooperation, uplifting social prosperity, and stimulating innovation. It presents global trends and innovations, advocates for inclusive digital transformation, and fosters a community of leaders shaping the digital future. It also highlights the DCO's impactful initiatives and showcases success stories from the network. Available in both digital and print formats, it is an invaluable resource for those committed to making a significant impact in the digital realm. https://www.dco.org/economix

Source: AETOSWire

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Ahmed Bayouni
Media@dco.org

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Takeda Presents Late-Breaking Data from Phase 2b Study of Mezagitamab, Demonstrating Potential to Transform Treatment of Primary Immune Thrombocytopenia23.6.2024 05:30:00 EEST | Press release

Takeda (TSE:4502/NYSE:TAK) today presented positive results from its Phase 2b, randomized, double-blind, placebo-controlled study evaluating the safety, tolerability and efficacy of mezagitamab (TAK-079) in patients with persistent or chronic primary immune thrombocytopenia (ITP), a rare immune-mediated bleeding disorder. ITP is characterized by the accelerated destruction of platelets in blood, resulting in a decreased platelet count and an increase of bleeding that can be debilitating. These data (Abstract #LB 01.1) were presented at the oral Late-Breakthrough Session at the 32nd Congress of the International Society on Thrombosis and Haemostasis (ISTH) in Bangkok, Thailand. Takeda plans to initiate a global Phase 3 trial of mezagitamab in patients with ITP in the second half of FY2024. The TAK-079-1004 trial (NCT04278924) evaluated three different doses of subcutaneous mezagitamab (100mg, 300mg and 600mg) versus placebo, given once weekly for eight weeks in patients with chronic or

PMC Biogenix Announces Expansion and Restructure22.6.2024 00:00:00 EEST | Press release

PMC Biogenix, the leading sustainable producer of specialty fatty amides and high-value biobased products, announces the construction and expansion of its new Armoslip® facility in Gyeongju, South Korea allowing for a production capacity increase of 50%. Construction will begin late 2024 with new supply available by mid-2026. “We are excited to announce plans to build a new facility in Gyeongju. This investment will allow us to significantly increase production capacity to meet growing customer demand for our Armoslip products,” said Debtosh Chakrabarti, President, PMC Group N.A., Inc. Adding, “This project solidifies our commitment as the industry leader, delivering products and solutions to our customers, as well as to the local Gyeongju community. We appreciate the continued support of the Gyeongju, South Korea local government, community, and our customers.” As part of PMC’s ongoing commitment of ensuring long-term sustainability and success of the Biogenix business world-wide, a c

Esri Technology Used By ALS Therapy Development Institute to Map Clinical Trials21.6.2024 23:58:00 EEST | Press release

The ALS Therapy Development Institute (ALS TDI), a nonprofit biotech dedicated to ending amyotrophic lateral sclerosis (ALS), has used mapping technology from Esri, the global leader in location intelligence, to develop the ALS Trial Navigator. The new tool is designed to simplify and streamline the process by which people with ALS and their caretakers learn about current ALS studies. With the ALS Trial Navigator users can now explore an interactive map to find locations where applicable clinical trials are taking place. They can also receive a customized map based on their preferences and status of their ALS. "ALS Trial Navigator helps people living with ALS, those that might face it in the future, and researchers looking to enroll trials by educating the community and providing information about current studies all around the world," said Dr. Nadia Sethi, ALS TDI's director of community engagement, who oversaw the Navigator's design and creation. Once a person is diagnosed with ALS,

Lifezone Metals Announces Voting Results from its 2024 Annual General Meeting21.6.2024 23:30:00 EEST | Press release

Lifezone Metals Limited (NYSE: LZM) announces the results of voting by shareholders at its 2024 Annual General Meeting (the “AGM”) held today in the Isle of Man. The ordinary resolutions below were passed by shareholders, with voting results as follows: Ordinary Resolutions For % For Against % Against Abstain % Abstain To receive the Company’s accounts for the financial year ended December 31, 2023 60,456,134 100.00% 0 0.00% 264 0.00% To re-elect John Dowd as a Class I Director of the Company 60,375,930 99.87% 79,177 0.13% 1,291 0.00% To re-elect Govind Friedland as a Class I Director of the Company 59,713,208 98.77% 79,319 0.13% 663,871 1.10% To re-elect Ambassador Mwanaidi Maajar as a Class I Director of the Company 60,314,469 99.77% 81,886 0.14% 60,043 0.10% A total of 60,456,398 or 75.57% of Lifezone Metals Ordinary Shares outstanding were represented at the AGM. If you would like to sign up for Lifezone Metals news alerts, please register here. About Lifezone Metals At Lifezone Me

Takeda Receives Approval from European Commission for FRUZAQLA in Previously Treated Metastatic Colorectal Cancer21.6.2024 23:00:00 EEST | Press release

Takeda (TSE:4502/NYSE:TAK) today announced that the European Commission (EC) approved FRUZAQLA (fruquintinib) as a monotherapy indicated for the treatment of adult patients with metastatic colorectal cancer (mCRC) who have been previously treated with available standard therapies, including fluoropyrimidine-, oxaliplatin-, and irinotecan-based chemotherapies, anti-VEGF agents, and anti-EGFR agents, and who have progressed on or are intolerant to treatment with either trifluridine-tipiracil or regorafenib. The decision follows a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) on April 25, 2024, and approval by the U.S. Food and Drug Administration (FDA) for adults with mCRC who have been previously treated with oxaliplatin- and irinotecan-based regimens on November 8, 2023.1,2 “People living with metastatic colorectal cancer face numerous difficulties, stemming both from their illness and the adverse effects of therapies. Given the complex nature of the d

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
HiddenA line styled icon from Orion Icon Library.Eye